Analytical Data
-
Gene name
ARF3
- Application
-
Alternative Names
ADP ribosylation factor 3; ADP-ribosylation factor 3; ARF3; ARF3_HUMAN; small GTP binding protein
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P61204
-
Expression Region
1-181aa
-
Molecular Weight
47.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARF3, a member of the ADP-ribosylation factor (ARF) family of proteins, plays a crucial role in regulating membrane trafficking and cytoskeletal dynamics in eukaryotic cells. It is involved in the organization of the Golgi apparatus, vesicle formation, and the transport of membrane proteins. The ARF family, consisting of several isoforms, has been extensively studied due to its significance in various cellular processes, including endocytosis, exocytosis, and signal transduction. Recent research has highlighted the potential of ARF3 as a key regulator in responses to cellular stress and as a player in developmental processes. Its dysregulation has been implicated in several diseases, including cancer and neurodegenerative disorders. The study of ARF3 recombinant protein has gained traction, particularly for its application in understanding the mechanisms underlying its function and interaction with other cellular components. By producing and characterizing ARF3 in vitro, researchers aim to elucidate its biochemical properties, binding partners, and the pathways it influences. Such insights are invaluable for developing therapeutic strategies targeting ARF3-related pathways in diseases. The ongoing exploration of ARF3 not only enriches our understanding of cellular biology but also holds promise for innovative approaches in biomedicine and molecular therapy.
